Core Laboratories N.V. (CLB) Misses Q3 EPS by 9c; Guides Q4 EPS, Revs
Core Laboratories N.V. (NYSE: CLB) reported Q3 EPS of $1.13, $0.09 worse than the analyst estimate of $1.22. Revenue for the quarter came in at $245.43 million versus the consensus estimate of $255.9 million.
Core Laboratories N.v. sees Q4 2012 EPS of $1.10-1.17, versus the consensus of $1.12. Core Laboratories N.v. sees Q4 2012 revenue of $245-250 million, versus the consensus of $252.1 million.
For earnings history and earnings-related data on Core Laboratories N.v. (CLB) click here.
Core Laboratories N.v. sees Q4 2012 EPS of $1.10-1.17, versus the consensus of $1.12. Core Laboratories N.v. sees Q4 2012 revenue of $245-250 million, versus the consensus of $252.1 million.
For earnings history and earnings-related data on Core Laboratories N.v. (CLB) click here.